`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`TWI PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`MERCK SERONO SA,
`Patent Owner.
`____________________________________________
`Case IPR2023-00049
`U.S. Patent No. 7,713,947
`____________________________________________
`
`DECLARATION OF GILLIAN T. FARRELL
`IN SUPPORT OF MOTION FOR ADMISSION PRO HAC VICE
`
`Merck 2073
`TWi v Merck
`IPR2023-00049
`
`
`
`
`Case No. IPR2023-00049
`Declaration of Gillian T. Farrell in Support of
`Motion for Admission Pro Hac Vice
`
`
`I, Gillian T. Farrell, declare as follows:
`
`
`1.
`
`I was admitted to the Massachusetts Bar in 2019 and the New York
`
`Bar in 2020. I have been practicing law for four years, with an emphasis on patent
`
`litigation in a variety of jurisdictions. I have had significant involvement in patent
`
`disputes in district court litigation. As part of my patent litigation experience, I
`
`have knowledge and experience with litigating invalidity/validity, defending and
`
`deposing fact and expert witnesses, handling evidentiary issues, and claim
`
`construction.
`
`2.
`
`I am a member in good standing of the Bars of Massachusetts and
`
`New York and am admitted to practice before the U.S. District Court for the
`
`District of Massachusetts.
`
`3.
`
`My Massachusetts Bar membership number is 705331. My New
`
`York Bar membership number is 5752670.
`
`4.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`5.
`
`I have never had a court or administrative body deny my application
`
`for admission to practice.
`
`6.
`
`I have never had any sanctions or contempt citations imposed on me
`
`by any court or administrative body.
`
`- 1 -
`
`
`
`Case No. IPR2023-00049
`Declaration of Gillian T. Farrell in Support of
`Motion for Admission Pro Hac Vice
`
`7.
`
`I have read and will comply with the Patent Office Trial Practice
`
`
`
`Guide and the Board’s Rules for Practice for Trials, as set forth in 37 C.F.R. Part
`
`42.
`
`8.
`
`I agree to be subject to the United States Patent and Trademark
`
`Office Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a).
`
`9.
`
`I have not appeared pro hac vice before the United States Patent and
`
`Trademark Office in the last three years.
`
`10.
`
`I am intimately familiar with the subject matter at issue in this
`
`proceeding. I participated in reviewing the papers filed in this proceeding. In
`
`addition to this proceeding, I participated in reviewing papers in the related inter
`
`partes review matters challenging U.S. Patent No. 7,713,947 (the “’947 patent”)
`
`and U.S. Patent No. 8,377,903 (the “’903 patent”), which were filed as Hopewell
`
`Pharma Ventures, Inc., v. Merck Serono SA, IPR2023-00480, and Hopewell
`
`Pharma Ventures, Inc., v. Merck Serono SA, IPR2023-00481, respectively.
`
`Moreover, I am currently representing Merck KGaA, Merck Serono SA, and Ares
`
`Trading SA (collectively, “Merck”) in the following consolidated district court
`
`litigation, in which the ’947 patent is a patent-in-suit: Merck KGaA, Merck Serono
`
`SA, and Ares Trading SA v. Hopewell Pharma Ventures, Inc., et al., No. 1:22-cv-
`
`- 2 -
`
`
`
`Case No. IPR2023-00049
`Declaration of Gillian T. Farrell in Support of
`Motion for Admission Pro Hac Vice
`
`
`01365-GBW (consolidated)1 (D. Del.).
`
`11.
`
`I will work in coordination and association with the designated lead
`
`counsel, Emily R. Whelan, for the duration of my involvement in this proceeding.
`
`12.
`
`I hereby declare that all statements made herein of my own
`
`knowledge are true and that all statements made on information and belief are
`
`believed to be true; and further that these statements are made with the knowledge
`
`that willful false statements and the like are punishable by fine, imprisonment, or
`
`both under Section 1001 of Title 18 of the United States Code.
`
`
`
`
`
`
`1 The following cases have been consolidated as Merck KGaA, Merck Serono SA,
`
`and Ares Trading SA v. Hopewell Pharma Ventures, Inc., et al., No. 1:22-cv-
`
`01365-GBW (D. Del.): Merck KGaA, Merck Serono SA, and Ares Trading SA v.
`
`Hopewell Pharma Ventures, Inc., No. 1:22-cv-01365-GBW (D. Del.); Merck
`
`KGaA, Merck Serono SA, and Ares Trading SA v. Aurobindo Pharma USA, Inc.
`
`and Aurobindo Pharma Limited, No. 1:23-cv-00039-GBW (D. Del.); and Merck
`
`KGaA, Merck Serono SA, and Ares Trading SA v. Apotex Inc. and Apotex Corp.,
`
`No. 1:23-cv-00655-GBW (D. Del.).
`
`- 3 -
`
`
`
`
`
`Dated: March 25, 2024
`
`
`
`
`
`
`
`
`Case No. IPR2023-00049
`Declaration of Gillian T. Farrell in Support of
`Motion for Admission Pro Hac Vice
`
`Respectfully Submitted,
`
`/Gillian T. Farrell/
`Gillian T. Farrell
`Wilmer Cutler Pickering
`Hale and Dorr LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`(212) 230-8800
`
`- 4 -
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
